OPKO Health Revenue 2010-2024 | OPK
OPKO Health revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| OPKO Health Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $863 |
| 2022 | $1,004 |
| 2021 | $1,775 |
| 2020 | $1,435 |
| 2019 | $902 |
| 2018 | $990 |
| 2017 | $966 |
| 2016 | $1,117 |
| 2015 | $492 |
| 2014 | $91 |
| 2013 | $97 |
| 2012 | $47 |
| 2011 | $28 |
| 2010 | $28 |
| 2009 | $4 |
| OPKO Health Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-03-31 | $174 |
| 2023-12-31 | $182 |
| 2023-09-30 | $179 |
| 2023-06-30 | $265 |
| 2023-03-31 | $238 |
| 2022-12-31 | $185 |
| 2022-09-30 | $180 |
| 2022-06-30 | $310 |
| 2022-03-31 | $329 |
| 2021-12-31 | $401 |
| 2021-09-30 | $386 |
| 2021-06-30 | $442 |
| 2021-03-31 | $545 |
| 2020-12-31 | $495 |
| 2020-09-30 | $428 |
| 2020-06-30 | $301 |
| 2020-03-31 | $211 |
| 2019-12-31 | $224 |
| 2019-09-30 | $229 |
| 2019-06-30 | $226 |
| 2019-03-31 | $222 |
| 2018-12-31 | $222 |
| 2018-09-30 | $250 |
| 2018-06-30 | $264 |
| 2018-03-31 | $255 |
| 2017-12-31 | $161 |
| 2017-09-30 | $246 |
| 2017-06-30 | $293 |
| 2017-03-31 | $266 |
| 2016-12-31 | $171 |
| 2016-09-30 | $298 |
| 2016-06-30 | $357 |
| 2016-03-31 | $291 |
| 2015-12-31 | $276 |
| 2015-09-30 | $143 |
| 2015-06-30 | $42 |
| 2015-03-31 | $30 |
| 2014-12-31 | $26 |
| 2014-09-30 | $20 |
| 2014-06-30 | $24 |
| 2014-03-31 | $22 |
| 2013-12-31 | $21 |
| 2013-09-30 | $21 |
| 2013-06-30 | $24 |
| 2013-03-31 | $31 |
| 2012-12-31 | $16 |
| 2012-09-30 | $12 |
| 2012-06-30 | $10 |
| 2012-03-31 | $9 |
| 2011-12-31 | $6 |
| 2011-09-30 | $7 |
| 2011-06-30 | $8 |
| 2011-03-31 | $7 |
| 2010-12-31 | $7 |
| 2010-09-30 | $6 |
| 2010-06-30 | $7 |
| 2010-03-31 | $8 |
| 2009-12-31 | $-2 |
| 2009-09-30 | $2 |
| 2009-06-30 | $2 |
| 2009-03-31 | $2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.032B | $0.864B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $231.755B | 27.80 |
| Intuitive Surgical (ISRG) | United States | $156.818B | 88.79 |
| Alcon (ALC) | Switzerland | $46.054B | 32.99 |
| IQVIA Holdings (IQV) | United States | $43.692B | 24.76 |
| IDEXX Laboratories (IDXX) | United States | $38.792B | 45.47 |
| Edwards Lifesciences (EW) | United States | $37.584B | 24.08 |
| DexCom (DXCM) | United States | $25.452B | 36.57 |
| STERIS (STE) | Ireland | $23.012B | 26.88 |
| Waters (WAT) | United States | $18.861B | 27.72 |
| Hologic (HOLX) | United States | $18.350B | 20.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.023B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.907B | 13.90 |
| Teleflex (TFX) | United States | $10.377B | 16.15 |
| Sysmex ADR (SSMXY) | Japan | $10.032B | 31.46 |
| Globus Medical (GMED) | United States | $9.732B | 28.53 |
| Penumbra (PEN) | United States | $6.917B | 78.60 |
| Glaukos (GKOS) | United States | $6.035B | 0.00 |
| Masimo (MASI) | United States | $5.796B | 33.33 |
| TransMedics (TMDX) | United States | $4.627B | 439.03 |
| Integer Holdings (ITGR) | United States | $3.914B | 22.90 |
| PROCEPT BioRobotics (PRCT) | United States | $3.182B | 0.00 |
| Inari Medical (NARI) | United States | $3.130B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.903B | 17.24 |
| Tandem Diabetes Care (TNDM) | United States | $2.587B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.477B | 10.80 |
| Veracyte (VCYT) | United States | $1.813B | 0.00 |
| RxSight (RXST) | United States | $1.646B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.526B | 0.00 |
| Artivion (AORT) | United States | $1.146B | 109.92 |
| Silk Road Medical (SILK) | United States | $1.066B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.062B | 20.66 |
| Pulse Biosciences (PLSE) | United States | $1.045B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.777B | 0.00 |
| Paragon 28 (FNA) | United States | $0.715B | 0.00 |
| SiBone (SIBN) | United States | $0.666B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.620B | 0.00 |
| IRadimed (IRMD) | United States | $0.602B | 33.70 |
| Mesa Laboratories (MLAB) | United States | $0.595B | 17.60 |
| Pacific Biosciences Of California (PACB) | United States | $0.581B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.479B | 0.00 |
| AxoGen (AXGN) | United States | $0.404B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.386B | 0.00 |
| Nevro (NVRO) | United States | $0.358B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.306B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.301B | 10.31 |
| Delcath Systems (DCTH) | United States | $0.242B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.236B | 11.96 |
| NeuroPace (NPCE) | United States | $0.229B | 0.00 |
| Inogen (INGN) | United States | $0.228B | 0.00 |
| CVRx (CVRX) | United States | $0.208B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.203B | 0.00 |
| 908 Devices (MASS) | United States | $0.200B | 0.00 |
| Accuray (ARAY) | United States | $0.191B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.185B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.173B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.148B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.113B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.103B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.103B | 21.62 |
| T2 Biosystems (TTOO) | United States | $0.089B | 0.00 |
| InspireMD (NSPR) | Israel | $0.085B | 0.00 |
| Hyperfine (HYPR) | United States | $0.083B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.081B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.077B | 0.00 |
| LENSAR (LNSR) | United States | $0.062B | 0.00 |
| Neuronetics (STIM) | United States | $0.057B | 0.00 |
| Vaso (VASO) | United States | $0.050B | 13.49 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| Envoy Medical (COCH) | United States | $0.042B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| DarioHealth (DRIO) | United States | $0.036B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.029B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.029B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.024B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.019B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |